doi: 10.1038/s41590-018-0110-6 [PMC free article] [PubMed] [CrossRef] [Google Scholar]Hannon_Lab GJ (2014). different cell types with unique functions. Efforts to isolate a specific Methyllycaconitine citrate cell type for analysis based on sorting techniques can be successful but these additional manipulations are both time consuming and have been shown to alter transcription (Haimon et al., 2018). The brain is a particularly challenging tissue in which to quantitate gene expression and translation. A typical mouse brain is made up of around 75 million neurons, 23 million glial cells, 7 million endothelial cells and several million other miscellaneous cell types Methyllycaconitine citrate (Williams, 2000). Neurons are extremely diverse in terms of their expression of various neurotransmitters, neuropeptides, and receptors and typically these neurons are anatomically intermingled making them very difficult to separate for molecular analysis. analysis of mRNA expression has been very useful in identifying the overall anatomical distribution of neurons expressing specific genes and the Allen Brain Institute has assembled a comprehensive database for both the mouse and human brain which is very useful. However, anatomical localization cannot define specific neuronal cell types. Characterization of the mRNA expression phenotype of specific neurons offers progressed with the development of ribosome-tagging methods, cell sorting based on promoter specific manifestation of Methyllycaconitine citrate fluorescent marker proteins, and single-cell RNA-Seq. Each approach offers advantages and disadvantages. In this protocol we describe a ribosome-tagging approach (RiboTag) which our lab developed (Sanz et al., 2009) and discuss the application of SA-2 this approach to the analysis of polyribosome connected mRNA transcripts in specific populations of neurons. The RiboTag approach takes advantage of the hundreds of specific promoter-driven Cre recombinase transgenics currently available (Jackson Laboratories offers more than 480 lines) while others are Methyllycaconitine citrate becoming added at a rapid pace. You will find two basic methods involving the use of RiboTag as diagrammed in Number 1 and each offers advantages and disadvantages. In the 1st approach we make use of a RiboTag mouse collection in which the 60S ribosomal gene, will be replaced with an HA-tagged exon efficiently labeling the cells polyribosomes so that they can become isolated by immunoprecipitation. These RiboTag mice are crossed to a Cre recombinase driver mouse collection and the double heterozygotes are used for analysis. Immunoprecipitation of polyribosomes from neuronal cells purifies only the polysomes that are tagged in the Cre-expressing cells. The mRNA from these polysomes is definitely isolated and the transcripts analyzed by qRT-PCR or RNA-Seq. The second approach utilizes a create inside a flex or DIO disease (AAV) flanked by two different units of loxP sites (Sanz et al., 2015). When the AAV-DIO-RiboTag is definitely injected into a specific anatomical region of the brain of an Methyllycaconitine citrate adult mouse the Rpl22-HA is only indicated in the neurons that are actively expressing Cre recombinase and also infected from the AAV. After waiting several weeks for the Rpl22-HA to be indicated and integrated into polyribosomes, cells samples are isolated and used to immunoprecipitate HA-tagged polyribosomes followed by qRT-PCR or RNA-Seq. The viral approach requires accurate stereotaxic injections of disease and is more labor rigorous but has the advantage that only adult neurons that still communicate the Cre transgenic will become targeted. The direct mix of RiboTag mice with Cre driver mice is easier to do but has the potential disadvantage the Rpl22-HA could continue to be indicated in neurons that have differentiated from a progenitor human population that indicated Cre recombinase at an earlier stage during development. One can take advantage of this difference by comparing results from the same mind region using the RiboTag mouse and the RiboTag disease using the same Cre driver transgenic. We have used this approach to demonstrate that embryonic Pomc-expressing progenitor neurons differentiate into both Agrp and Kiss1 expressing neurons in the adult arcuate nucleus of the hypothalamus (Sanz et al., 2015). Open in a separate window Number 1. Cartoon comparing the RiboTag mouse and AAV-DIO-RiboTag approachesOn the remaining part, the Rpl22 locus was revised by homologous recombination to place LoxP sites on either end of the last exon (Ex lover4) of the Rpl22 gene and a.
